Roche to provide HIV diagnostic solutions to Global Fund
18 June 2015 | By Victoria White
Roche has been selected to provide HIV-1 viral load and early infant diagnostic technologies for the Global Fund...
List view / Grid view
News
New mandatory logo for selling medicines online
18 June 2015 | By Victoria White
From 1 July, anyone in the UK selling medicines online needs to be registered with the MHRA and to be on the MHRA’s list of registered online retail sellers...
BGMA and MHRA come together for Quality Forum
The British Generic Manufacturers Association (BGMA) will stage the next meeting of its Quality Forum – in conjunction with the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) - on Wednesday, July 8th.
Boston Scientific launches Precision Novi Spinal Cord Stimulator System in Europe
18 June 2015 | By Victoria White
Boston Scientific has launched the Precision Novi Spinal Cord Stimulator System in Europe. It is the smallest high-capacity primary cell device available...
Merck Serono commits € 1.2 million to the Grant for Fertility Innovation (GFI) for 2015 / 16
18 June 2015 | By Victoria White
Merck Serono has announced its strong support of the Grant for Fertility Innovation (GFI) fund with grants totalling up to € 1.2 million for 2015 / 2016...
Genticel receives FDA clearance of IND application for US Phase 1 clinical trial of GTL001
17 June 2015 | By Victoria White
The FDA has cleared Genticel’s IND application to conduct in the US a Phase 1 study of GTL001 in patients infected with HPV 16 and/or 18...
Lilly and SCRI team up to develop investigational oncology therapy
17 June 2015 | By
Lilly and SCRI have entered a strategic partnership to co‑develop an investigational oncology compound, LY3023414, a PI3K/mTOR dual inhibitor...
Pancreatic cancer treatment pipeline dominated by early-stage development, says GBI Research
17 June 2015 | By Victoria White
The pancreatic cancer treatment pipeline is dominated by early-stage development, meaning many therapies are unlikely to reach the market in the near future...
First patient enrolled in Phase II trial of ImmunoPulse IL-12
17 June 2015 | By Victoria White
OncoSec has enrolled the first patient into a Phase II clinical trial of ImmunoPulse IL-12 in patients with squamous cell carcinoma of the head and neck...
Heptares announces positive outcome of Phase 1a study of HTL9936
17 June 2015 | By Victoria White
Heptares Therapeutics, the wholly-owned subsidiary of Sosei Group Corporation, has announced the positive outcome of its Phase 1a study with HTL9936...
Personalized medical technologies are high up on the agenda at BIOTECHNICA
17 June 2015 | By BIOTECHNICA
The world of medicine is changing fast, and “Personalized Medicine” is a very hot topic...
GARDASIL 9 HPV vaccine approved in the European Union
17 June 2015 | By Victoria White
GARDASIL 9 is approved in the EU for active immunisation against premalignant lesions and cancers affecting the cervix, vulva, vagina or anus...
FDA approves ZOMIG Nasal Spray migraine treatment for use in the US in paediatric patients
17 June 2015 | By Victoria White
The FDA has approved ZOMIG Nasal Spray for use in the US in paediatric patients 12 years of age and older for the treatment of migraine with or without aura...
Oncopeptides presents clinical results from Phase I/II study of melflufen and dexamethasone in patients with relapsed and relapsed refractory multiple myeloma
17 June 2015 | By Victoria White
Oncopeptides has presented results from an ongoing study of melflufen with dexamethasone in patients with relapsed and relapsed refractory multiple myeloma...
Astellas announces preliminary Phase 1/2 data for ASP2215 in patients with relapsed or refractory acute myeloid leukaemia
17 June 2015 | By Victoria White
Preliminary data from a Phase 1/2 trial on Astellas’ ASP2215 were presented at the European Haematology Association annual congress...
